Other Antiretrovirals in Development

Hydroxyurea | Remune | Valproic Acid | Other Drugs

See also: HIV Drugs in Development

Other Drugs

How Can "JAK Inhibitors" Help Salvage Patients and the Search for an HIV Cure? A Blog Entry by Nelson Vergel, B.S.Ch.E., M.B.A. (January 15, 2013)
An interview with Raymond Schinazi, Ph.D., D.Sc.
From TheBodyPRO.com
U.S. to Partner With Big Pharma for Drug Discovery (May 9, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir (April 17, 2012)
From National AIDS Treatment Advocacy Project
Study Questions Role of HDAC Inhibitors in HIV Cure Research (March 30, 2012)
In Michael Palm HIV Basic Science, Vaccines & Prevention Project Weblog, from Treatment Action Group
Tenofovir Pro-Drug GS-7340 Shows Good Safety and Efficacy in Short Study (March 8, 2012)
From aidsmap.com
Can a Drug for Psoriasis and MS Help Protect the Brain From HIV's Toxicity? (November/December 2011)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
Will An Antiretroviral Patch Help Adherence? Doubtful (October 29, 2011)
From Journal Watch
Monoclonal Antibody Ibalizumab May Hold Promise for Treatment-Experienced HIV Patients (October 4, 2011)
From HIVandHepatitis.com
Rogaine as Possible HIV Cure? (September 21, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Zinc Finger-Modified CD4-Cell Booster Transplant Working in Pilot Trial (September 21, 2011)
From National AIDS Treatment Advocacy Project

VIEW ALL ARTICLES

MOST VIEWED ARTICLES

	HIV Management Today: Mental Health & HIV, the Uncharted Territory
	Danish Study Targets HIV Reservoir, in Latest Search for HIV Cure
	10 Top Studies Whose Impact Will Last Well Beyond CROI 2013
	CROI 2013: Women's Issues in HIV Research (Video)
	PrEP Failures and Successes: One Study Whose Impact Will Last Well Beyond CROI 2013
	HIV Opportunistic Infection Guidelines Updated

More Most Viewed Articles

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.